Search
01/05/2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
Remon, J, Besse, B, Aix, SP, Callejo, A, Al-Rabi, K, Bernabe, R, Greillier, L, Majem, M, Reguart, N, Monnet, I, Cousin, S, Garrido, P, Robinet, G, Campelo, RG, Madroszyk, A, Mazieres, J, Curcio, H, Wasag, B, Pretzenbacher, Y, Fournier, B, Dingemans, AMC, Dziadziuszko, R. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial. ANNALS OF ONCOLOGY. 2023; 34(5)DOI:10.1016/j.annonc.2023.02.012. PMID:36863484. IF:56.700(Q1/1D).
01/05/2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
Lozano, R, Castro, E, -Campos, FL, Thorne, H, Ramirez-Backhaus, M, Aragon, IM, Cendon-Florez, Y, Gutierrez-Pecharroman, A, Salles, DC, Romero-Laorden, N, Lorente, D, Gonzalez-Peramato, P, Calatrava, A, Alonso, C, Anido, U, Arevalo-Lobera, S, Balmana, J, Chirivella, I, Juan-Fita, MJ, Llort, G, Cajal, TRY, Almagro, E, Alameda, D, Lopez-Casas, PP, Herrera, B, Mateo, J, Pritchard, CC, Antonarakis, ES, Lotan, TL, Rubio-Briones, J, Sandhu, S, Olmos, D. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. EUROPEAN JOURNAL OF CANCER. 2023; 185DOI:10.1016/j.ejca.2023.02.022. PMID:36972661. IF:7.600(Q1/2D).
01/05/2023
Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study
Espinosa, I, D'Angelo, E, De Brot, L, Prat, J. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. HUMAN PATHOLOGY. 2023; 135DOI:10.1016/j.humpath.2023.02.006. PMID:36863690. IF:2.700(Q2/4D).
01/05/2023
Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study
Martínez-Solano J., Ortiz-Bautista C., Gutiérrez-Ibañes E., García-Cosío M.D., Sarnago-Cebada F., Díaz-Molina B., Pascual I., Gómez-Bueno M., Calviño-Santos R., Gómez-Hospital J.A., García-Lara J., de la Fuente-Galán L., Mirabet-Pérez S., Martínez-Sellés M.. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study. REVISTA ESPANOLA DE CARDIOLOGIA. 2023; 76(5)DOI:10.1016/j.recesp.2022.09.001. PMID:36155847. IF:7.200(Q1/2D).
01/05/2023
DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood
Hahn, J, Bressler, J, Domingo-Relloso, A, Chen, MH, McCartney, DL, Teumer, A, van Dongen, J, Kleber, ME, Aissi, D, Swenson, BR, Yao, J, Zhao, W, Huang, J, Xia, YJ, Brown, MR, Costeira, R, de Geus, EJC, Delgado, GE, Dobson, DA, Elliott, P, Grabe, HJ, Guo, XQ, Harris, SE, Huffman, JE, Kardia, SLR, Liu, YM, Lorkowski, S, Marioni, RE, Nauck, M, Ratliff, SM, Sabater-Lleal, M, Spector, TD, Suchon, P, Taylor, KD, Thibord, F, Tregouet, DA, Wiggins, KL, Willemsen, G, Bell, JT, Boomsma, DI, Cole, SA, Cox, SR, Dehghan, A, Greinacher, A, Haack, K, Marz, W, Morange, PE, Rotter, JI, Sotoodehnia, N, Tellez-Plaza, M, Navas-Acien, A, Smith, JA, Johnson, AD, Fornage, M, Smith, NL, Wolberg, AS, Morrison, AC, de Vries, PS. DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2023; 21(5)DOI:10.1016/j.jtha.2023.01.015. PMID:36716967. IF:5.500(Q1/2D).
01/05/2023
Susceptibility to hepatitis B virus infection in adults living in Spain
Soriano, V, Aguilera, A, Benito, R, Gonzalez-Diez, R, Miro, E, Liendo, P, Rodriguez-Diaz, JC, Cabezas, T, Richart, A, Ramos, JM, Barea, L, Alvarez, C, Trevino, A, Gomez-Gallego, F, Corral, O, de Mendoza, C. Susceptibility to hepatitis B virus infection in adults living in Spain. LIVER INTERNATIONAL. 2023; 43(5)DOI:10.1111/liv.15548. PMID:36809581. IF:6.000(Q1/2D).
01/05/2023
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination
Pinana, JL, Martino, R, Vazquez, L, Lopez-Corral, L, Perez, A, Chorao, P, Avendano-Pita, A, Pascual, MJ, Sanchez-Salinas, A, Sanz-Linares, G, Olave, MT, Arroyo, I, Tormo, M, Villalon, L, Conesa-Garcia, V, Gago, B, Terol, MJ, Villalba, M, Garcia-Gutierrez, V, Cabero, A, Hernandez-Rivas, JA, Ferrer, E, Garcia-Cadenas, I, Teruel, A, Navarro, D, Cedillo, A, Sureda, A, Solano, C. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. BONE MARROW TRANSPLANTATION. 2023; 58(5)DOI:10.1038/s41409-023-01946-0. PMID:36854892. IF:4.500(Q1/2D).
01/05/2023
Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims
Navarrete, J, Colomer-Carbonell, A, Sanabria-Mazo, JP, Luciano, JV, Soler, J, Garcia-Campayo, J, Demarzo, M, Montero-Marin, J, Bohlmeijer, ET, Campos, D, Cebolla, A, Feliu-Soler, A. Psychometric properties of the engaged living scale (ELS) Spanish version in a large sample of Spanish pilgrims. Journal of Contextual Behavioral Science. 2023; 28DOI:10.1016/j.jcbs.2023.05.001. PMID:. IF:3.400(Q1/2D).